JP2015531789A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531789A5
JP2015531789A5 JP2015532458A JP2015532458A JP2015531789A5 JP 2015531789 A5 JP2015531789 A5 JP 2015531789A5 JP 2015532458 A JP2015532458 A JP 2015532458A JP 2015532458 A JP2015532458 A JP 2015532458A JP 2015531789 A5 JP2015531789 A5 JP 2015531789A5
Authority
JP
Japan
Prior art keywords
pyrrolysine
mutein
unnatural amino
conjugated
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015532458A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531789A (ja
JP6321658B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/069888 external-priority patent/WO2014044873A1/en
Publication of JP2015531789A publication Critical patent/JP2015531789A/ja
Publication of JP2015531789A5 publication Critical patent/JP2015531789A5/ja
Application granted granted Critical
Publication of JP6321658B2 publication Critical patent/JP6321658B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015532458A 2012-09-24 2013-09-24 アミノ酸誘導体 Expired - Fee Related JP6321658B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261705116P 2012-09-24 2012-09-24
US61/705,116 2012-09-24
US201361862495P 2013-08-05 2013-08-05
US61/862,495 2013-08-05
PCT/EP2013/069888 WO2014044873A1 (en) 2012-09-24 2013-09-24 Amino acid derivatives

Publications (3)

Publication Number Publication Date
JP2015531789A JP2015531789A (ja) 2015-11-05
JP2015531789A5 true JP2015531789A5 (enExample) 2018-03-29
JP6321658B2 JP6321658B2 (ja) 2018-05-09

Family

ID=49237211

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015532458A Expired - Fee Related JP6321658B2 (ja) 2012-09-24 2013-09-24 アミノ酸誘導体
JP2015532457A Active JP6532404B2 (ja) 2012-09-24 2013-09-24 細胞株

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015532457A Active JP6532404B2 (ja) 2012-09-24 2013-09-24 細胞株

Country Status (10)

Country Link
US (4) US9670521B2 (enExample)
EP (2) EP2897935B1 (enExample)
JP (2) JP6321658B2 (enExample)
KR (1) KR102155389B1 (enExample)
CN (2) CN104812734B (enExample)
AU (1) AU2013320184B2 (enExample)
BR (1) BR112015006368B1 (enExample)
CA (1) CA2885796C (enExample)
SG (2) SG11201502216UA (enExample)
WO (2) WO2014044873A1 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3202903B1 (en) 2010-12-22 2020-02-12 President and Fellows of Harvard College Continuous directed evolution
EP2852664B1 (en) 2012-05-18 2017-09-06 Medical Research Council Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase.
US9738724B2 (en) 2012-06-08 2017-08-22 Sutro Biopharma, Inc. Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
EP3135690A1 (en) 2012-06-26 2017-03-01 Sutro Biopharma, Inc. Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
US9670521B2 (en) 2012-09-24 2017-06-06 Medimmune Limited Amino acid derivatives
US10131920B2 (en) 2013-03-15 2018-11-20 Medimmune Limited Nucleic acid molecules
WO2015006555A2 (en) * 2013-07-10 2015-01-15 Sutro Biopharma, Inc. Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
CN105980350B (zh) 2013-08-05 2018-11-27 米迪缪尼有限公司 氨基酸衍生物
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
EP3097196B1 (en) 2014-01-20 2019-09-11 President and Fellows of Harvard College Negative selection and stringency modulation in continuous evolution systems
GB2528227A (en) * 2014-03-14 2016-01-20 Medical Res Council Cyclopropene amino acids and methods
US10920208B2 (en) 2014-10-22 2021-02-16 President And Fellows Of Harvard College Evolution of proteases
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
CN106146663B (zh) * 2015-04-10 2019-11-08 北京大学 非天然氨基酸标记的新型抗体-药物偶联物及其制备
US11299729B2 (en) 2015-04-17 2022-04-12 President And Fellows Of Harvard College Vector-based mutagenesis system
US10392674B2 (en) 2015-07-22 2019-08-27 President And Fellows Of Harvard College Evolution of site-specific recombinases
US11524983B2 (en) 2015-07-23 2022-12-13 President And Fellows Of Harvard College Evolution of Bt toxins
US10612011B2 (en) 2015-07-30 2020-04-07 President And Fellows Of Harvard College Evolution of TALENs
JP6967221B2 (ja) * 2015-08-19 2021-11-17 国立研究開発法人理化学研究所 非天然アミノ酸導入抗体
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
CN106929482A (zh) * 2015-12-31 2017-07-07 北京大学 定点突变的流感病毒、其活疫苗及其制备方法和应用
CN112725282A (zh) * 2016-01-27 2021-04-30 北京大学 携带正交tRNA/氨酰tRNA合成酶的稳定细胞系的构建
AU2017212739B2 (en) 2016-01-27 2024-03-21 Sutro Biopharma, Inc. Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
CN105524167A (zh) * 2016-01-30 2016-04-27 深圳市贝沃德克生物技术研究院有限公司 抗乙肝e抗原的绿色荧光抗体的制备方法
CN105647918A (zh) * 2016-02-20 2016-06-08 深圳市圣必智科技开发有限公司 抗乙肝e抗原的红色荧光抗体的制备方法
US10111966B2 (en) 2016-06-17 2018-10-30 Magenta Therapeutics, Inc. Methods for the depletion of CD117+ cells
US11214820B2 (en) * 2016-09-02 2022-01-04 Ikaria Inc. Functionally modified polypeptides and radiobiosynthesis
US10905107B2 (en) * 2016-09-05 2021-02-02 Korea Advanced Institute Of Science And Technology Transgenic mouse capable of spatial and temporal control of expression and site-specific modification of target protein, production method and uses thereof
WO2018044143A1 (ko) * 2016-09-05 2018-03-08 한국과학기술원 목적 단백질의 위치 특이적 변형이 시공간적으로 조절되는 마우스, 이의 제조방법 및 그 용도
EP3559018A1 (en) * 2016-12-23 2019-10-30 Bicyclerd Limited Peptide derivatives having novel linkage structures
SG11201906319XA (en) 2017-01-20 2019-08-27 Magenta Therapeutics Inc Compositions and methods for the depletion of cd137+ cells
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
US11447809B2 (en) 2017-07-06 2022-09-20 President And Fellows Of Harvard College Evolution of tRNA synthetases
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
US12060553B2 (en) 2017-08-25 2024-08-13 President And Fellows Of Harvard College Evolution of BoNT peptidases
US11624130B2 (en) 2017-09-18 2023-04-11 President And Fellows Of Harvard College Continuous evolution for stabilized proteins
CN111868079B (zh) 2017-12-27 2025-06-17 协和麒麟株式会社 Il-2变体
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11913044B2 (en) 2018-06-14 2024-02-27 President And Fellows Of Harvard College Evolution of cytidine deaminases
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
CN110835633B (zh) * 2018-08-13 2021-10-01 北京大学 利用优化的基因密码子扩展系统制备ptc稳定细胞系及应用
US20210356377A1 (en) * 2018-09-07 2021-11-18 Medimmune, Llc Methods Of Cell Selection
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
KR102559149B1 (ko) 2018-10-26 2023-07-24 에프. 호프만-라 로슈 아게 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
CN109553643B (zh) * 2018-11-29 2020-09-22 深圳先进技术研究院 单糖类似物及包含其的分子探针和该分子探针的应用
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
CN111850020B (zh) * 2019-04-25 2021-05-07 苏州鲲鹏生物技术有限公司 利用质粒系统在蛋白中引入非天然氨基酸
CN111909256A (zh) * 2019-05-10 2020-11-10 宁波鲲鹏生物科技有限公司 多肽衍生物及其制备方法
US12655182B2 (en) 2019-07-15 2026-06-16 President And Fellows Of Harvard College Evolved botulinum neurotoxins and uses thereof
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN114846030A (zh) * 2019-10-23 2022-08-02 佛罗里达大学研究基金会公司 催化抗体38c2的新型缀合化学
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头
WO2022056318A1 (en) * 2020-09-10 2022-03-17 Brickbio, Inc. Antibodies containing unnatural amino acids and methods of making and using the same
IL307830A (en) * 2021-04-21 2023-12-01 Asimov Inc Stable production systems for adeno-associated virus production
EP4330214A4 (en) * 2021-04-28 2025-11-26 Univ California BIOREACTIVE PROTEINS CONTAINING NON-NATURAL AMINO ACIDS
AU2021458069B2 (en) * 2021-07-29 2025-04-24 Novocodex Biopharmaceuticals Co., Ltd. Unnatural amino acid, and use thereof, recombinant protein containing same, and recombinant protein conjugate
EP4130254A1 (en) * 2021-08-03 2023-02-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Eukaryotic cell lysates comprising exogenous enzymes and methods for preparing the same
CN113788890B (zh) * 2021-09-01 2022-11-08 浙江新码生物医药有限公司 一种人白细胞介素2-聚乙二醇偶联物及其应用
CN113698468B (zh) * 2021-09-01 2022-10-11 浙江新码生物医药有限公司 人白细胞介素2-聚乙二醇偶联物及其应用
EP4399283A2 (en) * 2021-09-06 2024-07-17 Veraxa Biotech GmbH Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
WO2023164676A1 (en) * 2022-02-27 2023-08-31 The Regents Of The University Of California Methods to generate novel acyl-trna species
KR20250114384A (ko) * 2023-04-05 2025-07-29 케이제이 케미칼즈 가부시키가이샤 벤조일포름산아미드 유도체
JP2026519275A (ja) * 2023-04-28 2026-06-15 ユナイテッド キングダム リサーチ アンド イノベーション tRNAに基づく方法及び関連組成物
JP2026523745A (ja) * 2023-07-10 2026-07-14 スリオ セラピューティクス シーオー., エルティーディー. 官能基化アウリスタチン、医薬組成物、及び治療的応用
WO2026072574A1 (en) * 2024-09-25 2026-04-02 The Regents Of The University Of California Pylrs/trna pairs for producing proteins of interest

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711458A (en) 1969-08-21 1973-01-16 Research Corp Substituted and unsubstituted vinyloxycarbonyl groups as amino protecting groups in the syntheses of peptides
US4512979A (en) 1981-03-23 1985-04-23 Merck & Co., Inc. Dipeptides containing thialysine and related amino acids as antihypertensives
JPH0710451B2 (ja) 1986-11-25 1995-02-08 三五重機株式会社 鋼板カツタ−
HU207287B (en) 1989-01-17 1993-03-29 Biosignal Kutato Fejlesztoe Kf Polyene fatty acid derivatives of tyrozine-quinaze inhibiting activity and pharmaceutical composition containing them as active component
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
ES2464532T3 (es) 2001-04-19 2014-06-03 The Scripps Research Institute Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
EP2292273A3 (en) 2001-10-10 2011-11-23 BioGeneriX AG Remodeling and glycoconjugation of peptides
EP1558747B1 (en) 2002-10-16 2009-10-14 The Scripps Research Institute Glycoprotein synthesis
US20040146941A1 (en) * 2002-11-04 2004-07-29 Biliang Zhang Chemical encoding technology for combinatorial synthesis
JP5642916B2 (ja) * 2003-04-17 2014-12-17 ザ スクリプス リサーチ インスティテュート 真核遺伝コードの拡張
US7807619B2 (en) 2004-11-01 2010-10-05 The Regents Of The University Of California Compositions and methods for modification of biomolecules
JP2007037445A (ja) 2005-08-02 2007-02-15 Institute Of Physical & Chemical Research tRNA合成方法、核酸、アミノアシルtRNA合成方法及び非天然型アミノ酸組み込み蛋白質の製造方法
AU2007219793A1 (en) 2006-02-22 2007-09-07 Riken Method for synthesis of suppressor tRNA, DNA construct, and production of protein having non-natural amino acid integrated therein by using the DNA construct
CA2653748A1 (en) 2006-05-02 2007-11-15 Allozyne, Inc. Non-natural amino acid substituted polypeptides
CN101535338A (zh) * 2006-10-18 2009-09-16 斯克利普斯研究院 在哺乳动物细胞中将非天然氨基酸遗传掺入蛋白质
CN101952428B (zh) 2007-09-20 2013-10-23 独立行政法人理化学研究所 突变体吡咯赖氨酰-tRNA合成酶以及使用该酶的非天然氨基酸整合蛋白质的制造方法
CN102159803B (zh) 2008-07-18 2014-07-23 阿兰图姆公司 用于净化汽车尾气的过滤装置
EP2379578A4 (en) 2009-01-12 2012-05-02 Sutro Biopharma Inc DOUBLE-LOADING SYSTEM FOR THE SELECTIVE INTRODUCTION OF NON-NITIVE AMINO ACIDS IN PROTEINS DUE TO AN IN VITRO-SYNTHESIS PROCESS
US20100203587A1 (en) 2009-01-13 2010-08-12 Sutro Biopharma, Inc. Use of dna gyrase inhibitors for in vitro polypeptide synthesis reactions
WO2010114615A2 (en) 2009-04-03 2010-10-07 The Scripps Research Institute A facile system for encoding unnatural amino acids in mammalian cells
GB2470770A (en) * 2009-06-04 2010-12-08 Medical Res Council Incorporation of unnatural amino acids having an orthogonal functional group into polypeptides using orthogonal tRNA/tRNA synthetase pairs
WO2011044255A1 (en) 2009-10-06 2011-04-14 The Ohio State University Pyrrolysine analogs
EA201290541A1 (ru) * 2009-12-21 2013-05-30 Амбркс, Инк. Модифицированные бычьи соматотропиновые полипептиды и их применение
JP2013515081A (ja) 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用
US8859629B2 (en) 2010-04-27 2014-10-14 Synaffix B.V. Fused cyclooctyne compounds and their use in metal-free click reactions
CN103261222B (zh) 2010-09-10 2017-07-28 医疗免疫有限公司 抗体衍生物
DE102010041261A1 (de) * 2010-09-23 2012-03-29 Robert Bosch Gmbh Flip-Chip Anordnung mit einem Kühlelement und Verfahren zur Herstellung einer Flip-Chip Anordnung
US20130183761A1 (en) * 2010-09-24 2013-07-18 North Carolina State University Methods for Incorporating Unnatural Amino Acids in Eukaryotic Cells
ES2661095T3 (es) * 2011-02-03 2018-03-27 European Molecular Biology Laboratory Aminoácidos no naturales que comprenden un grupo análogo de ciclooctinilo o trans-ciclooctenilo y usos de los mismos
SI2890402T1 (sl) 2012-08-31 2019-07-31 Sutro Biopharma, Inc. Modificirane aminokisline vsebujoče acido skupino
US9670521B2 (en) 2012-09-24 2017-06-06 Medimmune Limited Amino acid derivatives
US10131920B2 (en) 2013-03-15 2018-11-20 Medimmune Limited Nucleic acid molecules

Similar Documents

Publication Publication Date Title
EP4410317A3 (en) Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP2020097577A5 (enExample)
EP4681777A3 (en) Prodrugs of ketamine, compositions and uses thereof
JP2019524883A5 (enExample)
JP2009523724A5 (enExample)
JP2016106149A5 (enExample)
JP2016531842A5 (enExample)
JP2017511360A5 (enExample)
JP2020507589A5 (enExample)
JP2019516739A5 (enExample)
JP2017515901A5 (enExample)
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
JP2016531871A5 (enExample)
JP2017531619A5 (enExample)
JP2013508279A5 (enExample)
JP2010500962A5 (enExample)
JP2020529994A5 (enExample)
JP2018505146A5 (enExample)
JP2016510326A5 (enExample)
JP2019510027A5 (enExample)
JP2015051983A5 (enExample)
JP2017517565A5 (enExample)
JP2014515407A5 (enExample)
JP2019535723A5 (enExample)
JP2018521056A5 (enExample)